Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015 (2015), Article ID 217258, 15 pages
http://dx.doi.org/10.1155/2015/217258
Research Article

Neuroprotection by Cocktails of Dietary Antioxidants under Conditions of Nerve Growth Factor Deprivation

1Laboratory of Neuroscience “R. Levi-Montalcini”, Department of Biotechnology and Biosciences, University of Milano-Bicocca, 20126 Milan, Italy
2SYSBIO Centre of Systems Biology, University of Milano-Bicocca, 20126 Milan, Italy
3Department of Sciences, University of Basilicata, 85100 Potenza, Italy
4NeuroMI Milan Center for Neuroscience, University of Milano-Bicocca, 20126 Milan, Italy

Received 18 May 2015; Revised 9 June 2015; Accepted 10 June 2015

Academic Editor: Steven McAnulty

Copyright © 2015 Flavio Amara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Fischer and O. Maier, “Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 610813, 18 pages, 2015. View at Publisher · View at Google Scholar
  2. C. Mancuso, G. Scapagnini, D. Currò et al., “Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders,” Frontiers in Bioscience, vol. 12, no. 3, pp. 1107–1123, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Lassmann, “Multiple sclerosis: lessons from molecular neuropathology,” Experimental Neurology A, vol. 262, pp. 2–7, 2014. View at Google Scholar
  4. J. Bournival, P. Quessy, and M.-G. Martinoli, “Protective effects of resveratrol and quercetin against MPP+-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons,” Cellular and Molecular Neurobiology, vol. 29, no. 8, pp. 1169–1180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Alberghina and A. M. Colangelo, “The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration,” BMC Neuroscience, vol. 7, supplement 1, article S2, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Levi-Montalcini, “Effects of mouse tumor transplantation on the nervous system,” Annals of the New York Academy of Sciences, vol. 55, no. 2, pp. 330–344, 1952. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Capsoni and A. Cattaneo, “On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease,” Cellular and molecular neurobiology, vol. 26, no. 4–6, pp. 619–633, 2006. View at Google Scholar · View at Scopus
  8. W. C. Mobley, J. L. Rutkowski, G. I. Tennekoon, J. Gemski, K. Buchanan, and M. V. Johnston, “Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons,” Brain Research, vol. 387, no. 1, pp. 53–62, 1986. View at Google Scholar · View at Scopus
  9. F. Ruberti, S. Capsoni, A. Comparini et al., “Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy,” The Journal of Neuroscience, vol. 20, no. 7, pp. 2589–2601, 2000. View at Google Scholar · View at Scopus
  10. M. R. Bianco, M. Berbenni, F. Amara et al., “Cross-talk between cell cycle induction and mitochondrial dysfunction during oxidative stress and nerve growth factor withdrawal in differentiated PC12 cells,” Journal of Neuroscience Research, vol. 89, no. 8, pp. 1302–1315, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. S. Wadia, R. M. E. Chalmers-Redman, W. J. H. Ju et al., “Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (–)-deprenyl,” Journal of Neuroscience, vol. 18, no. 3, pp. 932–947, 1998. View at Google Scholar · View at Scopus
  12. G. V. Putcha, C. A. Harris, K. L. Moulder, R. M. Easton, C. B. Thompson, and E. M. Johnson Jr., “Intrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from the analysis of mutant mice,” Journal of Cell Biology, vol. 157, no. 3, pp. 441–453, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Sampath and R. Perez-Polo, “Regulation of antioxidant enzyme expression by NGF,” Neurochemical Research, vol. 22, no. 4, pp. 351–362, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Salinas, R. Diaz, N. G. Abraham, C. M. R. de Galarreta, and A. Cuadrado, “Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner,” The Journal of Biological Chemistry, vol. 278, no. 16, pp. 13898–13904, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. I. Rojo, M. Salinas, D. Martín, R. Perona, and A. Cuadrado, “Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-κB,” The Journal of Neuroscience, vol. 24, no. 33, pp. 7324–7334, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Riccio, “The molecular basis of nutritional intervention in multiple sclerosis: a narrative review,” Complementary Therapies in Medicine, vol. 19, no. 4, pp. 228–237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Riccio and R. Rossano, “The role of nutrition in multiple sclerosis: a story yet to be written,” Revista Española de Esclerosis Múltiple, vol. 25, pp. 24–37, 2013. View at Google Scholar
  18. P. Riccio and R. Rossano, “Nutrition facts in multiple sclerosis,” ASN Neuro, vol. 7, no. 1, 2015. View at Publisher · View at Google Scholar
  19. L. Bravo, “Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance,” Nutrition Reviews, vol. 56, no. 11, pp. 317–333, 1998. View at Google Scholar · View at Scopus
  20. C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Rémésy, “Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies,” The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 230S–242S, 2005. View at Google Scholar · View at Scopus
  21. A. W. Boots, G. R. M. M. Haenen, and A. Bast, “Health effects of quercetin: from antioxidant to nutraceutical,” European Journal of Pharmacology, vol. 585, no. 2-3, pp. 325–337, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. de Santi, A. Pietrabissa, F. Mosca, and G. M. Pacifici, “Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver,” Xenobiotica, vol. 30, no. 11, pp. 1047–1054, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. E. J. Calabrese, M. P. Mattson, and V. Calabrese, “Resveratrol commonly displays hormesis: occurrence and biomedical significance,” Human and Experimental Toxicology, vol. 29, no. 12, pp. 980–1015, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Ramassamy, “Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets,” European Journal of Pharmacology, vol. 545, no. 1, pp. 51–64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Gan and L. Mucke, “Paths of convergence: sirtuins in aging and neurodegeneration,” Neuron, vol. 58, no. 1, pp. 10–14, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. L. Albarracin, B. Stab, Z. Casas et al., “Effects of natural antioxidants in neurodegenerative disease,” Nutritional Neuroscience, vol. 15, no. 1, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Szende, E. Tyihák, and Z. Király-Véghely, “Dose-dependent effect of resveratrol on proliferation and apoptosis in endothelial and tumor cell cultures,” Experimental and Molecular Medicine, vol. 32, no. 2, pp. 88–92, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Peltz, J. Gomez, M. Marquez et al., “Resveratrol exerts dosage and duration dependent effect on human mesenchymal stem cell development,” PLoS ONE, vol. 7, no. 5, Article ID e37162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. G. M. Liuzzi, T. Latronico, M. T. Branà et al., “Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients,” Neurochemical Research, vol. 36, no. 3, pp. 518–527, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. V. Rao and L. G. Rao, “Carotenoids and human health,” Pharmacological Research, vol. 55, no. 3, pp. 207–216, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Salinthone, V. Yadav, R. V. Schillace, D. N. Bourdette, and D. W. Carr, “Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling,” PLoS ONE, vol. 5, no. 9, Article ID e13058, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Morini, L. Roccatagliata, R. Dell'Eva et al., “Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis,” Journal of Neuroimmunology, vol. 148, no. 1-2, pp. 146–153, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Salinthone, V. Yadav, D. N. Bourdette, and D. W. Carr, “Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS,” Endocrine, Metabolic and Immune Disorders—Drug Targets, vol. 8, no. 2, pp. 132–142, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. E. L. B. Novelli, P. P. Santos, H. B. Assalin et al., “N-acetylcysteine in high-sucrose diet-induced obesity: energy expenditure and metabolic shifting for cardiac health,” Pharmacological Research, vol. 59, no. 1, pp. 74–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Bavarsad Shahripour, M. R. Harrigan, and A. V. Alexandrov, “N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities,” Brain and Behavior, vol. 4, no. 2, pp. 108–122, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. M. G. Boosalis, “The role of selenium in chronic disease,” Nutrition in Clinical Practice, vol. 23, no. 2, pp. 152–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M. A. Siddiqui, M. P. Kashyap, V. Kumar et al., “Differential protection of pre-, co- and post-treatment of curcumin against hydrogen peroxide in PC12 cells,” Human and Experimental Toxicology, vol. 30, no. 3, pp. 192–198, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Jazvinšćak Jembrek, L. Vuković, J. Puhović, J. Erhardt, and N. Oršolić, “Neuroprotective effect of quercetin against hydrogen peroxide-induced oxidative injury in P19 neurons,” Journal of Molecular Neuroscience, vol. 47, no. 2, pp. 286–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. L. A. Greene and A. S. Tischler, “Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 73, no. 7, pp. 2424–2428, 1976. View at Publisher · View at Google Scholar · View at Scopus
  40. B. L. Hempstead, S. J. Rabin, L. Kaplan, S. Reid, L. F. Parada, and D. R. Kaplan, “Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation,” Neuron, vol. 9, no. 5, pp. 883–896, 1992. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Conte, S. Pellegrini, and D. Tagliazucchi, “Synergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechin,” Brain Research Bulletin, vol. 62, no. 1, pp. 29–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Currò, A. Trovato-Salinaro, A. Gugliandolo et al., “Resveratrol protects against homocysteine-induced cell damage via cell stress response in neuroblastoma cells,” Journal of Neuroscience Research, vol. 93, no. 1, pp. 149–156, 2015. View at Publisher · View at Google Scholar
  43. M. J. McManus, M. P. Murphy, and J. L. Franklin, “Mitochondria-derived reactive oxygen species mediate caspase-dependent and -independent neuronal deaths,” Molecular and Cellular Neuroscience, vol. 63, pp. 13–23, 2014. View at Publisher · View at Google Scholar
  44. D. Martín, M. Salinas, R. López-Valdaliso, E. Serrano, M. Recuero, and A. Cuadrado, “Effect of the Alzheimer amyloid fragment Aβ(25–35) on Akt/PKB kinase and survival of PC12 cells,” Journal of Neurochemistry, vol. 78, no. 5, pp. 1000–1008, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. E. J. Ryu, J. M. Angelastro, and L. A. Greene, “Analysis of gene expression changes in a cellular model of Parkinson disease,” Neurobiology of Disease, vol. 18, no. 1, pp. 54–74, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Rodriguez-Blanco, V. Martín, F. Herrera, G. García-Santos, I. Antolín, and C. Rodriguez, “Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine,” Journal of Neurochemistry, vol. 107, no. 1, pp. 127–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. C. S. Casley, J. M. Land, M. A. Sharpe, J. B. Clark, M. R. Duchen, and L. Canevari, “Beta-amyloid fragment 25–35 causes mitochondrial dysfunction in primary cortical neurons,” Neurobiology of Disease, vol. 10, no. 3, pp. 258–267, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Sugino, M. Maruyama, M. Tanno, A. Kuno, K. Houkin, and Y. Horio, “Protein deacetylase SIRT1 in the cytoplasm promotes nerve growth factor-induced neurite outgrowth in PC12 cells,” FEBS Letters, vol. 584, no. 13, pp. 2821–2826, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Nakajima, N. Niisato, and Y. Marunaka, “Quercetin stimulates NGF-induced neurite outgrowth in PC12 cells via activation of Na+/K+/2Cl-,” Cellular Physiology and Biochemistry, vol. 28, no. 1, pp. 147–156, 2011. View at Publisher · View at Google Scholar
  50. L. M. Mendonça, C. da Silva Machado, C. C. Correia Teixeira, L. A. Pedro de Freitas, M. D. L. Pires Bianchi, and L. M. Greggi Antunes, “Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells,” NeuroToxicology, vol. 34, no. 1, pp. 205–211, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. G. Aliev, J. Liu, J. C. Shenk et al., “Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats,” Journal of Cellular and Molecular Medicine, vol. 13, no. 2, pp. 320–333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. L. L. Zamin, E. C. Filippi-Chiela, P. Dillenburg-Pilla, F. Horn, C. Salbego, and G. Lenz, “Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells,” Cancer Science, vol. 100, no. 9, pp. 1655–1662, 2009. View at Publisher · View at Google Scholar · View at Scopus